Skip to main content
. 2021 Aug;83(3):601–607. doi: 10.18999/nagjms.83.3.601

Table 2.

Patient demographics, indications for total hip arthroplasty (THA), comorbidities, preoperative medication, THA, postoperative blood transfusion, and THA dislocation on hospitalization

Characteristics With
postoperative
delirium
(n = 8)
Without
postoperative
delirium
(n = 730)
p value
Patient demographics
Age at THA (years)** 77
[65–82]
62
[22–92]
<0.001
Gender (men / women ratio) 3 / 5 102 / 628 0.092
Body mass index (kg/m2)* 22.8 ± 5.2 24.3 ± 4.0 0.446
Indications for THA
Primary hip osteoarthritis, n (%) 2 (25.0) 50 (6.8) 0.104
Developmental dysplasia of the hip, n (%) 4 (50.0) 619 (84.8) 0.024
Avascular necrosis of the femoral head, n (%) 1 (12.5) 27 (3.7) 0.267
Rapidly destructive coxarthrosis, n (%) 0 (0) 13 (1.8) 1.000
Rheumatoid arthritis, n (%) 0 (0) 9 (1.2) 1.000
Post-traumatic osteoarthritis, n (%) 1 (12.5) 6 (0.8) 0.074
Perthes’ disease, n (%) 0 (0) 6 (0.8) 1.000
Risk factors for falls
Visual deficit, n (%) 1 (12.5) 20 (2.7) 0.207
Age > 80 years, n (%) 3 (37.5) 46 (6.3) 0.012
Hemiplegia after cerebral infarction, n (%) 1 (12.5) 21 (2.9) 0.216
Use of postoperative ketamine and benzodiazepines, n (%) 2 (25.0) 39 (5.3) 0.068
Use of intraoperative opioids and ketamine, n (%) 0 (0) 0 (0) 1.000
Three or more medications, n (%) 5 (62.5) 306 (41.9) 0.292
Depression and Anxiety, n (%) 0 (0) 8 (1.1) 1.000
THA
Posterolateral approach, n (%) 8 (100) 730 (100) 1.000
Surgical time (minutes)** 41.0
[27.0–53.0]
42.0
[23.0–180.0]
0.334
Blood loss (mL)* 240.4 ± 117.5 274.9 ± 119.4 0.436
Postoperative blood transfusion, n (%) 2 (25.0) 116 (15.9) 0.621
THA dislocation on hospitalization
Falling from a standing position, n (%) 1 (12.5) 0 (0) 0.011
Moving in a deep-seated position on the bed, n (%) 0 (0) 3 (0.4) 1.000

THA: total hip arthroplasty

Normally and non-normally distributed variables are presented as the mean ± standard deviation and median [minimum - maximum] and were compared using *Student’s t-test and **the Mann-Whitney U-test, respectively.